North America & Europe Artificial Pancreas Systems Market Growth Driven By High Prevalence of Diabetes
Artificial pancreas is an insulin pump connected to a continuous glucose monitor. The monitor is controlled via a receiver using sophisticated software algorithms. It is used to help people with type 1 diabetes control their blood sugar levels. Currently available systems only deliver a single enzyme-based hormone insulin. Since the body usually produces insulin naturally, the use of an artificial pancreas can help diabetics lower their need for insulin by lessening the amount of the hormone that is produced and excreted. They are generally less expensive than a manual method. The growth of North America & Europe Artificial Pancreas Systems Market is driven by high prevalence of diabetes in the regions. For instance, according to International Diabetes Federation’s IDF Diabetes Atlas 2019 Edition, the numbers of adults with diabetes in the U.S. was 31.0 million. In Europe, 59,322,100 suffered from diabetes in 2019 and the number is expected to reach 68,121,400 in 2045. I...